191 related articles for article (PubMed ID: 9815946)
1. Regional loss of imprinting of the insulin-like growth factor II gene occurs in human prostate tissues.
Jarrard DF; Bussemakers MJ; Bova GS; Isaacs WB
Clin Cancer Res; 1995 Dec; 1(12):1471-8. PubMed ID: 9815946
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor (IGF)-I, IGF-II and IGF type I receptor (IGFR-I) expression in prostatic cancer.
Cardillo MR; Monti S; Di Silverio F; Gentile V; Sciarra F; Toscano V
Anticancer Res; 2003; 23(5A):3825-35. PubMed ID: 14666684
[TBL] [Abstract][Full Text] [Related]
3. [Genomic imprinting of insulin-like growth factor II in prostate cancer and its clinical significance].
Liu ZW; Zhou FJ; Luo YM; Qin ZK; Wang DJ; Luo JH; Han H; Li YH; Wang H
Ai Zheng; 2006 Jun; 25(6):765-70. PubMed ID: 16764778
[TBL] [Abstract][Full Text] [Related]
4. Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis.
Nosho K; Yamamoto H; Taniguchi H; Adachi Y; Yoshida Y; Arimura Y; Endo T; Hinoda Y; Imai K
Clin Cancer Res; 2004 Dec; 10(23):7950-7. PubMed ID: 15585629
[TBL] [Abstract][Full Text] [Related]
5. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
Kaplan PJ; Mohan S; Cohen P; Foster BA; Greenberg NM
Cancer Res; 1999 May; 59(9):2203-9. PubMed ID: 10232609
[TBL] [Abstract][Full Text] [Related]
6. Recurrence of urothelial carcinoma of the bladder: a role for insulin-like growth factor-II loss of imprinting and cytoplasmic E-cadherin immunolocalization.
Gallagher EM; O'Shea DM; Fitzpatrick P; Harrison M; Gilmartin B; Watson JA; Clarke T; Leonard MO; McGoldrick A; Meehan M; Watson C; Furlong F; O'Kelly P; Fitzpatrick JM; Dervan PA; O'Grady A; Kay EW; McCann A
Clin Cancer Res; 2008 Nov; 14(21):6829-38. PubMed ID: 18980977
[TBL] [Abstract][Full Text] [Related]
7. Relaxation of imprinting of human insulin-like growth factor II gene, IGF2, in sporadic breast carcinomas.
Wu HK; Squire JA; Catzavelos CG; Weksberg R
Biochem Biophys Res Commun; 1997 Jun; 235(1):123-9. PubMed ID: 9196048
[TBL] [Abstract][Full Text] [Related]
8. Maintenance of genomic imprinting at the IGF2 locus in hepatoblastoma.
Davies SM
Cancer Res; 1993 Oct; 53(20):4781-3. PubMed ID: 8402661
[TBL] [Abstract][Full Text] [Related]
9. IGF-II in primary human colorectal tumors: peptide level, activated promoters, parental imprinting and gene rearrangement.
Winkler R; Delacroix L; Bensbaho K; Lambert S; Collette J; Hodzic D
Horm Metab Res; 1999; 31(2-3):148-54. PubMed ID: 10226796
[TBL] [Abstract][Full Text] [Related]
10. Loss of imprinting of human insulin-like growth factor II gene, IGF2, in acute myeloid leukemia.
Wu HK; Weksberg R; Minden MD; Squire JA
Biochem Biophys Res Commun; 1997 Feb; 231(2):466-72. PubMed ID: 9070302
[TBL] [Abstract][Full Text] [Related]
11. [Loss of imprinting of insulin-like growth factor II gene in acute myeloid leukemia].
Liu Y; Yang B; Zhu H; Wang J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Feb; 17(1):39-41. PubMed ID: 10653908
[TBL] [Abstract][Full Text] [Related]
12. Malignant breast epithelium selects for insulin-like growth factor II expression in breast stroma: evidence for paracrine function.
Singer C; Rasmussen A; Smith HS; Lippman ME; Lynch HT; Cullen KJ
Cancer Res; 1995 Jun; 55(11):2448-54. PubMed ID: 7757999
[TBL] [Abstract][Full Text] [Related]
13. Loss of imprinting of the insulin-like growth factor II gene in renal cell carcinoma.
Nonomura N; Nishimura K; Miki T; Kanno N; Kojima Y; Yokoyama M; Okuyama A
Cancer Res; 1997 Jul; 57(13):2575-7. PubMed ID: 9205056
[TBL] [Abstract][Full Text] [Related]
14. [In situ hybridization to detect the mRNA for insulin-like growth factor-I and II in the prostate].
Deng F; Zhao X; Gu F
Zhonghua Wai Ke Za Zhi; 1996 Dec; 34(12):748-50. PubMed ID: 9590778
[TBL] [Abstract][Full Text] [Related]
15. Loss of imprinting of the IGF-II and H19 genes in epithelial ovarian cancer.
Chen CL; Ip SM; Cheng D; Wong LC; Ngan HY
Clin Cancer Res; 2000 Feb; 6(2):474-9. PubMed ID: 10690526
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor II messenger ribonucleic acid expression in Wilms tumor, nephrogenic rest, and kidney.
Yun K; Molenaar AJ; Fiedler AM; Mark AJ; Eccles MR; Becroft DM; Reeve AE
Lab Invest; 1993 Nov; 69(5):603-15. PubMed ID: 7504120
[TBL] [Abstract][Full Text] [Related]
17. Loss of imprinting of the insulin-like growth factor II gene in mouse hepatocellular carcinoma cell lines.
Ooasa T; Karasaki H; Kanda H; Nomura K; Kitagawa T; Ogawa K
Mol Carcinog; 1998 Dec; 23(4):248-53. PubMed ID: 9869454
[TBL] [Abstract][Full Text] [Related]
18. Blockade of the type I IGF receptor expression in human prostate cancer cells inhibits proliferation and invasion, up-regulates IGF binding protein-3, and suppresses MMP-2 expression.
Grzmil M; Hemmerlein B; Thelen P; Schweyer S; Burfeind P
J Pathol; 2004 Jan; 202(1):50-9. PubMed ID: 14694521
[TBL] [Abstract][Full Text] [Related]
19. Genomic imprinting of insulin-like growth factor-2 in infant leukemia and childhood neuroblastoma.
Hattori H; Matsuzaki A; Suminoe A; Ihara K; Eguchi M; Tajiri T; Suita S; Ishii E; Hara T
Cancer; 2000 May; 88(10):2372-7. PubMed ID: 10820361
[TBL] [Abstract][Full Text] [Related]
20. Promoter-dependent tissue-specific expressive nature of imprinting gene, insulin-like growth factor II, in human tissues.
Wu HK; Squire JA; Song Q; Weksberg R
Biochem Biophys Res Commun; 1997 Apr; 233(1):221-6. PubMed ID: 9144427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
